Literature DB >> 29507003

Response by Lerman et al to Letters Regarding Article, "Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study".

Joseph B Lerman1, Aditya A Joshi1, David A Bluemke2, Nehal N Mehta1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29507003      PMCID： PMC5844358          DOI： 10.1161/CIRCULATIONAHA.117.031675

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  Comprehensive plaque assessment by coronary CT angiography.

Authors:  Pál Maurovich-Horvat; Maros Ferencik; Szilard Voros; Béla Merkely; Udo Hoffmann
Journal:  Nat Rev Cardiol       Date:  2014-04-22       Impact factor: 32.419

Review 2.  What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.

Authors:  E Puzenat; V Bronsard; S Prey; P-A Gourraud; S Aractingi; M Bagot; B Cribier; P Joly; D Jullien; M Le Maitre; C Paul; M-A Richard-Lallemand; J-P Ortonne; F Aubin
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-04       Impact factor: 6.166

3.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

4.  Inflammation and Atherosclerosis: The End of a Controversy.

Authors:  Göran K Hansson
Journal:  Circulation       Date:  2017-09-15       Impact factor: 29.690

5.  Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.

Authors:  Joseph B Lerman; Aditya A Joshi; Abhishek Chaturvedi; Tsion M Aberra; Amit K Dey; Justin A Rodante; Taufiq Salahuddin; Jonathan H Chung; Anshuma Rana; Heather L Teague; Jashin J Wu; Martin P Playford; Benjamin A Lockshin; Marcus Y Chen; Veit Sandfort; David A Bluemke; Nehal N Mehta
Journal:  Circulation       Date:  2017-05-08       Impact factor: 29.690

6.  Risk of myocardial infarction in patients with psoriasis.

Authors:  Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

7.  Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.

Authors:  Jashin J Wu; Kwun-Yee T Poon; Jennifer C Channual; Albert Yuh-Jer Shen
Journal:  Arch Dermatol       Date:  2012-11

Review 8.  Unraveling Vascular Inflammation: From Immunology to Imaging.

Authors:  Heather L Teague; Mark A Ahlman; Abass Alavi; Denisa D Wagner; Andrew H Lichtman; Matthias Nahrendorf; Filip K Swirski; Frank Nestle; Joel M Gelfand; Mariana J Kaplan; Steven Grinspoon; Paul M Ridker; David E Newby; Ahmed Tawakol; Zahi A Fayad; Nehal N Mehta
Journal:  J Am Coll Cardiol       Date:  2017-09-12       Impact factor: 24.094
  8 in total
  1 in total

1.  Dysfunction of regulatory T cells mediated by AKT-FOXO1 signaling pathway occurs during the development of psoriasis.

Authors:  Zhixia Fan; Lingyu Li; Xin Wang; Guoying Miao
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.